Correlation Between Eurofins Scientific and Neovacs SA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eurofins Scientific and Neovacs SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eurofins Scientific and Neovacs SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eurofins Scientific SE and Neovacs SA, you can compare the effects of market volatilities on Eurofins Scientific and Neovacs SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eurofins Scientific with a short position of Neovacs SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eurofins Scientific and Neovacs SA.

Diversification Opportunities for Eurofins Scientific and Neovacs SA

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Eurofins and Neovacs is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Eurofins Scientific SE and Neovacs SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neovacs SA and Eurofins Scientific is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eurofins Scientific SE are associated (or correlated) with Neovacs SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neovacs SA has no effect on the direction of Eurofins Scientific i.e., Eurofins Scientific and Neovacs SA go up and down completely randomly.

Pair Corralation between Eurofins Scientific and Neovacs SA

Assuming the 90 days trading horizon Eurofins Scientific is expected to generate 53.09 times less return on investment than Neovacs SA. But when comparing it to its historical volatility, Eurofins Scientific SE is 22.59 times less risky than Neovacs SA. It trades about 0.06 of its potential returns per unit of risk. Neovacs SA is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  0.03  in Neovacs SA on August 30, 2024 and sell it today you would earn a total of  0.00  from holding Neovacs SA or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Eurofins Scientific SE  vs.  Neovacs SA

 Performance 
       Timeline  
Eurofins Scientific 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eurofins Scientific SE has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's technical and fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Neovacs SA 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Neovacs SA are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Neovacs SA reported solid returns over the last few months and may actually be approaching a breakup point.

Eurofins Scientific and Neovacs SA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eurofins Scientific and Neovacs SA

The main advantage of trading using opposite Eurofins Scientific and Neovacs SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eurofins Scientific position performs unexpectedly, Neovacs SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neovacs SA will offset losses from the drop in Neovacs SA's long position.
The idea behind Eurofins Scientific SE and Neovacs SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
CEOs Directory
Screen CEOs from public companies around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities